Evaluation of the lymph flow using Indocyanine green (ICG) fluorescence during colorectal surgery

Evaluation of the lymph flow using Indocyanine green (ICG) fluorescence during colorectal surgery - Evaluation of the lymph flow using Indocyanine green (ICG) fluorescence during colorectal surgery

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000045238

Enrollment

200

Registered

2021-08-25

Start date

2021-08-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Injection of ICG (2.5mg/ml) for the assessment of lymph flow at the begining of colorectal cancer surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Colorectal cancer patients who are planed to receive laparoscopic colectomy / proctectomy with lymph node dissection

Exclusion criteria

Exclusion criteria: Patients with ICG allergy Patients with iodine allergy Recurrent cases Patients who are planed to receive palliative surgery

Design outcomes

Primary

Measure	Time frame
Positive rate of the additional dissected lymph node metastasis	—

Countries

Japan

Contacts

Public ContactTakeshi Nishikawa

Saitama Cancer Center Department of gastrointestinal surgery

tnishikawa@saitama-pho.jp+81-48-722-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026